Argan Interest Coverage vs Capex To Revenue Analysis

AGX Stock

USD 157.02 1.61 1.01%

Argan financial indicator trend analysis is way more than just evaluating Argan Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Argan Inc is a good investment. Please check the relationship between Argan Interest Coverage and its Capex To Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Argan Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Interest Coverage vs Capex To Revenue

Interest Coverage vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Argan Inc Interest Coverage account and Capex To Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Argan's Interest Coverage and Capex To Revenue is -0.18. Overlapping area represents the amount of variation of Interest Coverage that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Argan Inc, assuming nothing else is changed. The correlation between historical values of Argan's Interest Coverage and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Coverage of Argan Inc are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Interest Coverage i.e., Argan's Interest Coverage and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.18

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Interest Coverage

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Argan's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Argan Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Argan Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

At this time, Argan's Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 10.83 in 2024, despite the fact that Discontinued Operations is likely to grow to (243.7 K).

	2021	2022	2023	2024 (projected)
Total Operating Expenses	47.3M	44.7M	44.4M	46.6M
Cost Of Revenue	409.6M	368.7M	494.5M	519.2M

Total Operating Expenses Cost Of Revenue

Argan fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Other Current Assets	Accounts Payable	Common Stock Total Equity	Common Stock	Current Deferred Revenue
Total Assets		0.25	0.54	0.86	0.9	0.79	-0.42	0.87	0.35	0.85	0.22	0.91	0.75	0.56	0.14	0.22	0.55	0.86	0.72	1.0	0.25	0.53	0.68	0.68	0.69	0.68
Short Long Term Debt Total	0.25		0.47	0.31	0.14	0.15	-0.11	0.28	0.1	0.05	0.23	0.04	0.3	-0.08	-0.03	0.32	-0.22	0.32	0.53	0.27	0.55	0.04	-0.15	0.19	0.19	0.31
Other Current Liab	0.54	0.47		0.55	0.41	0.43	-0.12	0.51	0.02	0.44	0.58	0.3	0.57	0.14	-0.03	0.62	-0.01	0.56	0.69	0.54	0.44	0.29	0.15	0.35	0.36	0.45
Total Current Liabilities	0.86	0.31	0.55		0.56	0.48	-0.44	0.56	0.36	0.56	0.23	0.81	0.55	0.39	-0.26	0.3	0.3	1.0	0.61	0.88	0.24	0.18	0.61	0.53	0.54	0.94
Total Stockholder Equity	0.9	0.14	0.41	0.56		0.88	-0.33	0.94	0.29	0.91	0.15	0.8	0.76	0.6	0.45	0.09	0.66	0.56	0.65	0.88	0.19	0.71	0.59	0.67	0.68	0.32
Property Plant And Equipment Net	0.79	0.15	0.43	0.48	0.88		-0.26	0.86	0.21	0.89	0.25	0.62	0.74	0.43	0.33	0.23	0.51	0.49	0.78	0.77	0.48	0.73	0.36	0.54	0.55	0.27
Net Debt	-0.42	-0.11	-0.12	-0.44	-0.33	-0.26		-0.16	-0.98	-0.2	0.14	-0.57	0.08	-0.59	0.05	0.16	-0.54	-0.44	-0.13	-0.44	-0.08	-0.43	-0.06	-0.55	-0.55	-0.56
Retained Earnings	0.87	0.28	0.51	0.56	0.94	0.86	-0.16		0.1	0.83	0.43	0.66	0.87	0.34	0.45	0.37	0.36	0.57	0.79	0.85	0.4	0.65	0.47	0.51	0.52	0.3
Cash	0.35	0.1	0.02	0.36	0.29	0.21	-0.98	0.1		0.16	-0.22	0.55	-0.17	0.64	-0.04	-0.26	0.58	0.36	0.01	0.37	0.04	0.44	0.09	0.59	0.59	0.47
Non Current Assets Total	0.85	0.05	0.44	0.56	0.91	0.89	-0.2	0.83	0.16		0.14	0.73	0.78	0.62	0.31	0.16	0.65	0.57	0.64	0.82	0.14	0.6	0.61	0.69	0.69	0.32
Non Currrent Assets Other	0.22	0.23	0.58	0.23	0.15	0.25	0.14	0.43	-0.22	0.14		-0.05	0.48	-0.2	-0.02	0.94	-0.49	0.25	0.52	0.23	0.56	0.19	-0.08	0.07	0.07	0.13
Cash And Short Term Investments	0.91	0.04	0.3	0.81	0.8	0.62	-0.57	0.66	0.55	0.73	-0.05		0.44	0.69	0.03	-0.1	0.73	0.81	0.39	0.91	0.03	0.52	0.78	0.69	0.7	0.68
Net Receivables	0.75	0.3	0.57	0.55	0.76	0.74	0.08	0.87	-0.17	0.78	0.48	0.44		0.22	0.34	0.53	0.17	0.56	0.86	0.74	0.3	0.29	0.41	0.43	0.44	0.31
Common Stock Shares Outstanding	0.56	-0.08	0.14	0.39	0.6	0.43	-0.59	0.34	0.64	0.62	-0.2	0.69	0.22		0.16	-0.24	0.87	0.38	0.08	0.54	-0.3	0.42	0.57	0.94	0.93	0.32
Non Current Liabilities Total	0.14	-0.03	-0.03	-0.26	0.45	0.33	0.05	0.45	-0.04	0.31	-0.02	0.03	0.34	0.16		-0.06	0.25	-0.26	0.18	0.11	-0.12	0.38	0.01	0.16	0.16	-0.42
Inventory	0.22	0.32	0.62	0.3	0.09	0.23	0.16	0.37	-0.26	0.16	0.94	-0.1	0.53	-0.24	-0.06		-0.54	0.31	0.59	0.22	0.54	0.04	-0.15	0.05	0.05	0.22
Other Stockholder Equity	0.55	-0.22	-0.01	0.3	0.66	0.51	-0.54	0.36	0.58	0.65	-0.49	0.73	0.17	0.87	0.25	-0.54		0.29	0.04	0.53	-0.33	0.51	0.58	0.71	0.71	0.2
Total Liab	0.86	0.32	0.56	1.0	0.56	0.49	-0.44	0.57	0.36	0.57	0.25	0.81	0.56	0.38	-0.26	0.31	0.29		0.62	0.88	0.25	0.19	0.6	0.53	0.53	0.94
Property Plant And Equipment Gross	0.72	0.53	0.69	0.61	0.65	0.78	-0.13	0.79	0.01	0.64	0.52	0.39	0.86	0.08	0.18	0.59	0.04	0.62		0.72	0.63	0.36	0.13	0.35	0.36	0.47
Total Current Assets	1.0	0.27	0.54	0.88	0.88	0.77	-0.44	0.85	0.37	0.82	0.23	0.91	0.74	0.54	0.11	0.22	0.53	0.88	0.72		0.26	0.51	0.67	0.67	0.68	0.71
Short Term Debt	0.25	0.55	0.44	0.24	0.19	0.48	-0.08	0.4	0.04	0.14	0.56	0.03	0.3	-0.3	-0.12	0.54	-0.33	0.25	0.63	0.26		0.45	-0.25	-0.05	-0.05	0.19
Other Current Assets	0.53	0.04	0.29	0.18	0.71	0.73	-0.43	0.65	0.44	0.6	0.19	0.52	0.29	0.42	0.38	0.04	0.51	0.19	0.36	0.51	0.45		0.22	0.44	0.44	0.0
Accounts Payable	0.68	-0.15	0.15	0.61	0.59	0.36	-0.06	0.47	0.09	0.61	-0.08	0.78	0.41	0.57	0.01	-0.15	0.58	0.6	0.13	0.67	-0.25	0.22		0.53	0.53	0.41
Common Stock Total Equity	0.68	0.19	0.35	0.53	0.67	0.54	-0.55	0.51	0.59	0.69	0.07	0.69	0.43	0.94	0.16	0.05	0.71	0.53	0.35	0.67	-0.05	0.44	0.53		1.0	0.43
Common Stock	0.69	0.19	0.36	0.54	0.68	0.55	-0.55	0.52	0.59	0.69	0.07	0.7	0.44	0.93	0.16	0.05	0.71	0.53	0.36	0.68	-0.05	0.44	0.53	1.0		0.44
Current Deferred Revenue	0.68	0.31	0.45	0.94	0.32	0.27	-0.56	0.3	0.47	0.32	0.13	0.68	0.31	0.32	-0.42	0.22	0.2	0.94	0.47	0.71	0.19	0.0	0.41	0.43	0.44

Click cells to compare fundamentals

Argan Account Relationship Matchups

Argan fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	487.5M	602.6M	553.6M	489.5M	598.2M	628.1M
Other Current Liab	34.3M	45.7M	51.9M	48.3M	79.0M	82.9M
Total Current Liabilities	144.0M	276.1M	223.0M	202.5M	302.3M	317.4M
Total Stockholder Equity	339.2M	320.7M	326.4M	280.9M	290.9M	305.5M
Property Plant And Equipment Net	24.9M	24.1M	14.5M	16.5M	18.5M	19.5M
Net Debt	(165.2M)	(364.6M)	(346.8M)	(172.4M)	(191.7M)	(182.1M)
Retained Earnings	189.3M	166.1M	188.7M	207.8M	225.5M	236.8M
Cash	167.4M	366.7M	350.5M	173.9M	197.0M	101.4M
Non Current Assets Total	65.8M	56.4M	46.3M	50.8M	51.1M	53.6M
Non Currrent Assets Other	408K	249K	457K	3.7M	2.3M	2.4M
Cash And Short Term Investments	327.9M	456.7M	440.5M	325.5M	306.5M	321.8M
Net Receivables	70.6M	55.3M	31.9M	74.9M	113.8M	119.5M
Common Stock Shares Outstanding	15.6M	15.8M	15.9M	14.2M	13.5M	8.1M
Liabilities And Stockholders Equity	487.5M	602.6M	553.6M	489.5M	598.2M	628.1M
Non Current Liabilities Total	2.5M	4.1M	5.0M	6.1M	5.0M	3.5M
Other Stockholder Equity	148.7M	153.3M	137.8M	73.6M	66.7M	62.3M
Total Liab	146.5M	280.2M	228.0M	208.6M	307.3M	322.7M
Property Plant And Equipment Gross	22.5M	24.1M	14.5M	16.5M	40.1M	42.1M
Total Current Assets	421.8M	546.2M	507.3M	438.7M	547.2M	574.5M
Short Term Debt	1.6M	2.1M	1.4M	1.6M	2.7M	1.6M
Other Current Assets	23.3M	34.1M	34.2M	26.4M	11.0M	8.6M
Accumulated Other Comprehensive Income	(1.1M)	(1.1M)	(2.5M)	(2.9M)	(3.6M)	(3.4M)
Accounts Payable	35.4M	53.3M	41.8M	56.4M	39.5M	29.8M
Common Stock Total Equity	2.3M	2.4M	2.4M	2.4M	2.7M	1.6M
Common Stock	2.3M	2.4M	2.4M	2.4M	2.7M	1.7M
Current Deferred Revenue	72.7M	172.0M	127.9M	96.3M	181.1M	190.1M
Other Assets	7.9M	249K	457K	3.7M	4.2M	4.5M
Property Plant Equipment	22.5M	20.4M	10.5M	10.4M	12.0M	7.7M
Good Will	34.3M	32.8M	27.9M	28.0M	32.2M	24.6M
Short Term Investments	160.5M	90.1M	90.0M	151.5M	109.5M	81.3M
Intangible Assets	5.0M	4.1M	3.3M	2.6M	2.2M	4.0M
Other Liab	1.8M	4.1M	2.7M	2.9M	3.3M	3.5M
Net Tangible Assets	306.3M	288.6M	295.0M	250.3M	287.8M	248.8M
Noncontrolling Interest In Consolidated Entity	(196K)	1.8M	1.7M	(797K)	(916.6K)	(870.7K)
Retained Earnings Total Equity	189.3M	166.1M	188.7M	207.8M	239.0M	148.9M
Capital Surpluse	148.7M	153.3M	158.2M	162.2M	186.5M	142.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Argan Stock Analysis

When running Argan's price analysis, check to measure Argan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argan is operating at the current time. Most of Argan's value examination focuses on studying past and present price action to predict the probability of Argan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argan's price. Additionally, you may evaluate how the addition of Argan to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Argan Interest Coverage vs Capex To Revenue Analysis

Interest Coverage vs Capex To Revenue

Interest Coverage vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Interest Coverage

Capex To Revenue

Argan fundamental ratios Correlations

Argan Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Argan fundamental ratios Accounts

Also Currently Popular

Additional Tools for Argan Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Common Stock	+ 1.0	Common Stock Total Equity
Current Deferred Revenue	+ 0.94	Total Current Liabilities
Retained Earnings	+ 0.94	Total Stockholder Equity
Inventory	+ 0.94	Non Currrent Assets Other

Cash	- 0.98	Net Debt
Common Stock Shares Outstanding	- 0.59	Net Debt
Cash And Short Term Investments	- 0.57	Net Debt
Current Deferred Revenue	- 0.56	Net Debt
Common Stock	- 0.55	Net Debt
Common Stock Total Equity	- 0.55	Net Debt